Chromosomal abnormality scores unlock path to personalized immunotherapy
In a newly published article in Nature Genetics, researchers from the University of Chicago have identified tumor aneuploidy—an imbalance in the number of chromosomes—as a powerful biomarker associated with resistance ...
15 hours ago
0
24